MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Mama Loves to Eat on MSN
Why tomatoes tasted better 50 years ago - and how science might fix it
Ever bite into a supermarket tomato and wonder where all the flavor went? You're not imagining things. That watery, cardboard ...
MUTE-Seq uses ultra-precise FnCas9-AF2 to remove wild-type DNA, sharply boosting detection of rare cancer mutations down to 0 ...
If you have been wondering whether CRISPR Therapeutics at around $57 a share is a bargain or a bubble, you are not alone. This stock sits at the crossroads of high science and high expectations. The ...
Chinese scientists have genetically tweaked a fungus to make protein-rich “meat”, which they say can be a low-cost, ...
AZoLifeSciences on MSN
Syntax Bio develops CRISPR technology to program stem cell gene activity
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
A one-year-old baby boy has received an incredible honour, for helping researchers get one step closer to finding treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback